Skip to main content
. 2023 Mar 24;149(10):7493–7503. doi: 10.1007/s00432-023-04707-0

Fig. 1.

Fig. 1

Number of incident malignant neoplasms (a) and carcinoma in situ (with and without cervix uteri) (b) from March 2019 to February 2021, stratified by period (pre-pandemic: March 2019 to February 2020; pandemic: March 2020 to February 2021) and month of year